Identification of candidate circulating cisplatin-resistant biomarkers from epithelial ovarian carcinoma cell secretomes
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of candidate circulating cisplatin-resistant biomarkers from epithelial ovarian carcinoma cell secretomes
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 110, Issue 1, Pages 123-132
Publisher
Springer Nature
Online
2013-11-01
DOI
10.1038/bjc.2013.687
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- curatedOvarianData: clinically annotated data for the ovarian cancer transcriptome
- (2013) Benjamin Frederick Ganzfried et al. Database-The Journal of Biological Databases and Curation
- Sp1 is involved in regulation of cystathionine γ-lyase gene expression and biological function by PI3K/Akt pathway in human hepatocellular carcinoma cell lines
- (2012) Peng Yin et al. CELLULAR SIGNALLING
- Phosphoglycerate dehydrogenase induces glioma cells proliferation and invasion by stabilizing forkhead box M1
- (2012) Jinlong Liu et al. JOURNAL OF NEURO-ONCOLOGY
- The Ubiquitin Peptidase UCHL1 Induces G0/G1 Cell Cycle Arrest and Apoptosis Through Stabilizing p53 and Is Frequently Silenced in Breast Cancer
- (2012) Tingxiu Xiang et al. PLoS One
- Matrix Metalloproteinase-10 Is Required for Lung Cancer Stem Cell Maintenance, Tumor Initiation and Metastatic Potential
- (2012) Verline Justilien et al. PLoS One
- Tumor and Salivary Matrix Metalloproteinase Levels Are Strong Diagnostic Markers of Oral Squamous Cell Carcinoma
- (2011) M. Stott-Miller et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Differentially expressed genes associated with cisplatin resistance in human ovarian adenocarcinoma cell line A2780
- (2011) Peter Solár et al. CANCER LETTERS
- Urinary MMP-2 and MMP-9 predict the presence of ovarian cancer in women with normal CA125 levels
- (2011) Christine M. Coticchia et al. GYNECOLOGIC ONCOLOGY
- A High-Confidence Human Plasma Proteome Reference Set with Estimated Concentrations in PeptideAtlas
- (2011) Terry Farrah et al. MOLECULAR & CELLULAR PROTEOMICS
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis
- (2011) Jason W Locasale et al. NATURE GENETICS
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Proteomic Analysis of Ovarian Cancer Proximal Fluids: Validation of Elevated Peroxiredoxin 1 in Patient Peripheral Circulation
- (2011) Ebony R. Hoskins et al. PLoS One
- Matrix Metalloproteinase-10 Promotes Kras-Mediated Bronchio-Alveolar Stem Cell Expansion and Lung Cancer Formation
- (2011) Roderick P. Regala et al. PLoS One
- The principle of exhaustiveness versus the principle of parsimony: a new approach for the identification of biomarkers from proteomic spot volume datasets based on principal component analysis
- (2010) Emilio Marengo et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1
- (2010) Hoon Kim et al. BMC Medical Genomics
- Assessment of Buffer Systems for Harvesting Proteins from Tissue Interstitial Fluid for Proteomic Analysis
- (2010) Pang-ning Teng et al. JOURNAL OF PROTEOME RESEARCH
- Differential Proteomic Analysis of Renal Cell Carcinoma Tissue Interstitial Fluid
- (2010) Pang-ning Teng et al. JOURNAL OF PROTEOME RESEARCH
- A Gene Signature Predictive for Outcome in Advanced Ovarian Cancer Identifies a Survival Factor: Microfibril-Associated Glycoprotein 2
- (2009) Samuel C. Mok et al. CANCER CELL
- A prognostic gene expression index in ovarian cancer-validation across different independent data sets
- (2009) Carsten Denkert et al. JOURNAL OF PATHOLOGY
- Comprehensive Analysis of Conditioned Media from Ovarian Cancer Cell Lines Identifies Novel Candidate Markers of Epithelial Ovarian Cancer
- (2009) C. Geeth Gunawardana et al. JOURNAL OF PROTEOME RESEARCH
- Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma
- (2009) Barbara Seliger et al. Journal of Translational Medicine
- Matrix metalloproteinase-7 and -13 expression associate to cisplatin resistance in head and neck cancer cell lines
- (2009) Anna Ansell et al. ORAL ONCOLOGY
- A Gene Signature Predicting for Survival in Suboptimally Debulked Patients with Ovarian Cancer
- (2008) T. Bonome et al. CANCER RESEARCH
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
- (2008) R. W. Tothill et al. CLINICAL CANCER RESEARCH
- Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors
- (2008) Jun Yu et al. HEPATOLOGY
- Mining the Ovarian Cancer Ascites Proteome for Potential Ovarian Cancer Biomarkers
- (2008) Cynthia Kuk et al. MOLECULAR & CELLULAR PROTEOMICS
- Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer
- (2008) A. Agarwal et al. MOLECULAR CANCER THERAPEUTICS
- Mining the plasma proteome for cancer biomarkers
- (2008) Samir M. Hanash et al. NATURE
- Proteomic Analysis of Ovarian Cancer Cells Reveals Dynamic Processes of Protein Secretion and Shedding of Extra-Cellular Domains
- (2008) Vitor M. Faça et al. PLoS One
- A Proteome Resource of Ovarian Cancer Ascites: Integrated Proteomic and Bioinformatic Analyses To Identify Putative Biomarkers
- (2007) Limor Gortzak-Uzan et al. JOURNAL OF PROTEOME RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started